VANCOUVER, British Columbia--(BUSINESS WIRE)--Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics as a new category in regenerative medicine, today ...

Aspect Biosystems Ltd. has secured additional government funding to expand its capacity to 3-D print live tissue implants that can replace organ functions. The Vancouver-based company said Thursday ...

Novo Nordisk A/S NVO and a privately-held biotechnology company, Aspect Biosystems, announced entering a collaboration, development, and license agreement. This will bring together Aspect’s ...

An Aspect Biosystem scientist at work on a company bioprinter. (Aspect Photo) Vancouver, B.C.-based biotech company Aspect Biosystems inked a partnership worth potentially more than $2.6 billion with ...

FILE PHOTO: The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, December 3, 2025. REUTERS/Tom Little/File Photo ...

Strengthening British Columbia's life sciences sector by supporting projects that advance emerging Canadian technologies and enhance the innovation ecosystem VANCOUVER, BC, April 2, 2026 /CNW/ - Today ...

Aspect Biosystems, a biotechnology company pioneering a novel category of regenerative medicine, today announced that it has received a $79 million investment from the Government of Canada. The ...

The Government of Canada is reportedly contributing $79 million to support Aspect Biosystems, a Vancouver-based biotechnology company pioneering the development of bioprinted tissue therapeutics. The ...